Cullinan Therapeutics (CGEM) Asset Utilization Ratio (2021)
Cullinan Therapeutics' (CGEM) Asset Utilization Ratio came in at 0.04 for Q4 2021.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Asset Utilization Ratio (2021) Analysis & Trends
For FY2021, Cullinan Therapeutics' Asset Utilization Ratio stood at 0.06.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Cullinan Therapeutics | 919.35 Mn | 584.85 Mn | - | - |
API Access
Cullinan Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CGEM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "CGEM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CGEM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();